CoChat
Sign Up
Cited by 8

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Ph− myeloproliferative neoplasm red blood cells display deregulation of IQGAP1-Rho GTPase signaling depending on CALR/JAK2 status

Socoro-Yuste, Nuria, Dagher, Marie-Claire, Gonzalez De Peredo, Anne, Mondet, Julie, Zaccaria, Affif, Roux Dalvai, Florence, Plo, Isabelle, Cahn, Jean Yves, Mossuz, Pascal·2016·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
DOI 10.1016/j.bbamcr.2016.08.012
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2016.08.012

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. Vardiman, 2002, The World Health Organization (WHO) classification of the myeloid neoplasms, Blood, 100, 2292, 10.1182/blood-2002-04-1199 · DOI
  2. Vardiman, 2009, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, 114, 937, 10.1182/blood-2009-03-209262 · DOI
  3. Klampfl, 2013, Somatic mutations of calreticulin in myeloproliferative neoplasms, N. Engl. J. Med., 369, 2379, 10.1056/NEJMoa1311347 · DOI · Paper page
  4. Nangalia, 2013, Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2, N. Engl. J. Med., 369, 2391, 10.1056/NEJMoa1312542 · DOI · Paper page
  5. Tefferi, 2007, Evaluation of “increased” hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests, Mayo Clin. Proc., 82, 599, 10.4065/82.5.599 · DOI
  6. Mossuz, 2004, Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis, Haematologica, 89, 1194
  7. Tefferi, 2011, Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study, J. Clin. Oncol., 29, 1356, 10.1200/JCO.2010.32.9490 · DOI
  8. Mossuz, 2007, Apolipoprotein A1: a new serum marker correlated to JAK2 V617F proportion at diagnosis in patients with polycythemia vera, Proteomics Clin. Appl., 1, 1605, 10.1002/prca.200601051 · DOI
  9. Mossuz, 2008, Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia, Exp. Hematol., 36, 1642, 10.1016/j.exphem.2008.07.013 · DOI
  10. Falanga, 2005, Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils, Semin. Hematol., 42, 239, 10.1053/j.seminhematol.2005.05.023 · DOI
  11. Hui, 2013, Aberrant expression of signaling proteins in essential thrombocythemia, Ann. Hematol., 92, 1229, 10.1007/s00277-013-1755-8 · DOI
  12. Wautier, 2007, Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM, Blood, 110, 894, 10.1182/blood-2006-10-048298 · DOI
  13. De Grandis, 2013, JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway, Blood, 121, 658, 10.1182/blood-2012-07-440487 · DOI
  14. El Nemer, 2010, Role of Lu/BCAM glycoproteins in red cell diseases, Transfus. Clin. Biol., 17, 143, 10.1016/j.tracli.2010.06.002 · DOI
  15. Murphy, 2005, Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU, Blood, 105, 3322, 10.1182/blood-2004-07-2881 · DOI
  16. Villanueva, 2006, Automated serum peptide profiling, Nat. Protoc., 1, 880, 10.1038/nprot.2006.128 · DOI
  17. Plo, 2008, JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders, Blood, 112, 1402, 10.1182/blood-2008-01-134114 · DOI
  18. Ligeti, 2004, Phospholipids can switch the GTPase substrate preference of a GTPase-activating protein, J. Biol. Chem., 279, 5055, 10.1074/jbc.C300547200 · DOI
  19. Brown, 2006, IQGAP1 in cellular signaling: bridging the GAP, Trends Cell Biol., 16, 242, 10.1016/j.tcb.2006.03.002 · DOI
  20. Grohmanova, 2004, Phosphorylation of IQGAP1 modulates its binding to Cdc42, revealing a new type of rho-GTPase regulator, J. Biol. Chem., 279, 48495, 10.1074/jbc.M408113200 · DOI
  21. Jacquemet, 2013, IQGAP1 is a key node within the small GTPase network, Small GTPases, 4, 199, 10.4161/sgtp.27451 · DOI
  22. McCallum, 1996, Identification of a putative effector for Cdc42Hs with high sequence similarity to the RasGAP-related protein IQGAP1 and a Cdc42Hs binding partner with similarity to IQGAP2, J. Biol. Chem., 271, 21732, 10.1074/jbc.271.36.21732 · DOI
  23. Owen, 2008, The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions: interfaces differ between the complexes, J. Biol. Chem., 283, 1692, 10.1074/jbc.M707257200 · DOI
  24. White, 2009, IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis, FEBS Lett., 583, 1817, 10.1016/j.febslet.2009.05.007 · DOI
  25. Yamaoka-Tojo, 2004, IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species—dependent endothelial migration and proliferation, Circ. Res., 95, 276, 10.1161/01.RES.0000136522.58649.60 · DOI
  26. Erickson, 1997, Identification of an actin cytoskeletal complex that includes IQGAP and the Cdc42 GTPase, J. Biol. Chem., 272, 24443, 10.1074/jbc.272.39.24443 · DOI
  27. Jameson, 2013, IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors, Nat. Med., 19, 626, 10.1038/nm.3165 · DOI
  28. Johnson, 2009, IQGAP1 regulation and roles in cancer, Cell. Signal., 21, 1471, 10.1016/j.cellsig.2009.02.023 · DOI
  29. Sanchez-Laorden, 2013, Mind the IQGAP, Cancer Cell, 23, 715, 10.1016/j.ccr.2013.05.017 · DOI
  30. White, 2012, IQGAP1 and its binding proteins control diverse biological functions, Cell. Signal., 24, 826, 10.1016/j.cellsig.2011.12.005 · DOI
  31. Tekletsadik, 2012, A conserved role of IQGAP1 in regulating TOR complex 1, J. Cell Sci., 125, 2041
  32. Wang, 2009, IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway, J. Cell Sci., 122, 2024, 10.1242/jcs.044644 · DOI
  33. Ory, 2011, Rho GTPases and exocytosis: what are the molecular links?, Semin. Cell Dev. Biol., 22, 27, 10.1016/j.semcdb.2010.12.002 · DOI
  34. Radu, 2014, PAK signalling during the development and progression of cancer, Nat. Rev. Cancer, 14, 13, 10.1038/nrc3645 · DOI
  35. Ye, 2012, PAK signaling in cancer, Cell Logist., 2, 105, 10.4161/cl.21882 · DOI
  36. Wennerberg, 2005, The Ras superfamily at a glance, J. Cell Sci., 118, 843, 10.1242/jcs.01660 · DOI · Paper page
  37. Mulloy, 2010, Rho GTPases in hematopoiesis and hemopathies, Blood, 115, 936, 10.1182/blood-2009-09-198127 · DOI
  38. Chachoua, 2016, Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants, Blood, 127, 1325, 10.1182/blood-2015-11-681932 · DOI
  39. Elf, 2016, Mutant calreticulin requires both its mutant C-terminus and the Thrombopoietin receptor for oncogenic transformation, Cancer Discov., 6, 368, 10.1158/2159-8290.CD-15-1434 · DOI · Paper page
  40. Liu, 2014, Conserved sequence repeats of IQGAP1 mediate binding to Ezrin, J. Proteome Res., 13, 1156, 10.1021/pr400787p · DOI

Cited by

See all 8

Metadata

Authors
Socoro-Yuste, N., Dagher, M.-C., Gonzalez De Peredo, A., Mondet, J., Zaccaria, A., Roux Dalvai, F., Plo, I., Cahn, J. Y., & Mossuz, P.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2016-11
Volume
1863
Issue
11
Pages
2758-2765
ISSN
0167-4889
DOI
10.1016/j.bbamcr.2016.08.012
Cited by
8
References
1
Language
en
Licence
Funders
Centre de Ressources Biologiques-CRB (BB-0033-00069)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review